title: Hepato-preferential insulins: Is this the end, or the end of the beginning?
authors: Department of Diabetes & Endocrinology, Royal Surrey County Hospital, University of Surrey - Cedar Centre, Guildford, UK. davidrussell-jones@nhs.net.
authors: D L
authors: DL
authors: Russell-Jones
mesh_terms: D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007328:Insulin / Q000031:analogs & derivatives*; D061268:Insulin Lispro / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism*
chemical_list: D007328:Insulin; D061268:Insulin Lispro